Qingdao Haier Biomedical

Qingdao Haier Biomedical is engaged in research and development, production and sales of biomedical cryogenic storage devices using IoT.

Business Model: B2C

Revenue: $0

Employees: 0-0

Rankings

Detailed Qingdao Haier Biomedical Information

Geographic Data

Qingdao Haier Biomedical headquarters map

Address:

City:

State:

Zip:

Country:

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$0

Metrics

0Website Global Rank

0Website Monthly Traffic

Twitter Followers

Description

Haier Biosciences comprehensively promotes the integration and innovation of IoT technology and low-temperature storage technology. Traditional storage devices are upgraded to IoT scenarios to meet the iterative needs of users such as clinical blood use, vaccination, and biobank applications, and build an IoT technology ecosystem. The blood network scenario program is based on the "Cloud Wing" Internet of Things blood cold storage box network device, which links blood collection, blood delivery and clinical blood use scenarios to achieve the full traceability of blood information from "blood donor" to "blood user". The vaccine network scenario plan is based on the "Haile Miao" vaccination box network device, linking the vaccination entrance and exit scenes, realizing the traceability of the last mile of vaccination, and the transparent and visible matching of the vaccine to ensure the safety of the vaccine. Vaccine Network has launched more than 500 vaccination sites across the country, and will build the country’s first fully-covered smart city vaccine network in Shenzhen, and enter 78 countries and regions including participating countries of the “Belt and Road”. 120,000 Internet of Things vaccination box-net devices have protected the health of 200 million children worldwide. The biological sample network scenario plan is based on the "cloud core" IoT ultra-low temperature storage box network device, which links sample collection, storage, and application scenarios to achieve cloud-network collaboration, accurate sample positioning, one-click access, and information traceability to promote samples Management change.

Contact Phone:

Contact Email:

Qingdao Haier Biomedical went public on 10/25/2019 on the SSE

Listed Exchange:
SSE

IPO Date:
10/25/2019

Ticker Symbol:
688139

Live

Opened: -/share

EBITDA -
Total Cash -
Total Debt -
Total Revenue -
Total Profit (Gross) -
PE Ratio -
Announced Date Company Transaction Money Raised
3/2021 HISTO Series B -
3/2021 HISTO Series B -

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research